Buda Juice is rated a 'sell' due to its current valuation at about 8 times sales, which is considered unjustified given its modest revenue growth and risks related to execution. The company's FY 2025 revenue was $12.6 million, significantly below full capacity, with a gross margin contraction to 44.4% and a free cash flow yield just over 2.3%. Although a distribution partnership with Country Fresh offers some scale, minority shareholders face risks of value leakage and limited upside potential. The price target ranges from $6.50 to $10.70, but achieving this depends on doubling revenue, which current growth rates and utilization levels do not support.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
B&M European Value Retail's first-quarter update has divided analysts, with Deutsche Bank upgrading the stock to 'hold' citing stabilizing profit margins and a sensible turnaround strategy by new CEO Tjeerd Jegen. Deutsche Bank raised its profit fore...
AmpliTech Group marked its fifth anniversary as a public company by ringing the Nasdaq opening bell and announcing record revenue of $25.2 million in fiscal 2025, a 165% increase year-over-year. The company, a US-based leader in RF and microwave sign...
Telo Genomics announced positive interim results from a clinical study analyzing blood samples of multiple myeloma patients to predict relapse risk using 3D telomere analysis. The test showed strong predictive accuracy, potentially offering a less in...
Meta now notifies parents if their teen talks about suicide or self-harm with its AI chatbot and is developing a feature to contact emergency services if risk is detected. This move addresses concerns about AI chatbots handling crisis conversations, ...
